Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for …

R Shukla, TR Singh - Journal of Biomolecular Structure and …, 2019 - Taylor & Francis
… From here, we have predicted 297 potent inhibitors. These … CDK5 changes when the
interaction between CDK5 and p25 … and interacting residues obtained after molecular docking are …

novel medicinal chemistry strategies targeting CDK5 for Drug Discovery

W Tang, C Lin, Q Yu, D Zhang, Y Liu… - Journal of Medicinal …, 2023 - ACS Publications
… The crystal structure of the CDK5-Roscovitine complex … HCT-116, with the most potent inhibition
observed in MCF-7 (IC … criteria, focused screening, and biological evaluation. Of note, 10 …

[HTML][HTML] Computational simulations identify pyrrolidine-2, 3-dione derivatives as novel inhibitors of Cdk5/p25 complex to attenuate Alzheimer's pathology

A Zeb, D Kim, SI Alam, M Son, R Kumar… - Journal of Clinical …, 2019 - mdpi.com
Cdk5 in complex with p25 (Cdk5/p25) and Roscovitine was … the tested inhibitors occupied
the ATP-binding site of Cdk5/p25 (… all the hit molecules obtained almost similar conformational …

Phloretin and phloridzin improve insulin sensitivity and enhance glucose uptake by subverting PPARγ/Cdk5 interaction in differentiated adipocytes

S Kumar, K Sinha, R Sharma, R Purohit… - Experimental cell …, 2019 - Elsevier
… was subjected to molecular simulation of docked complexes. … in comparison to roscovitine
(selective Cdk5 inhibitor). The … Gene expression analysis of leptin revealed its strong inhibition

[HTML][HTML] Marine-derived compounds for CDK5 Inhibition in Cancer: Integrating multi-stage virtual screening, MM/GBSA analysis and molecular dynamics …

TH Shoaib, MA Almogaddam, YS Andijani, SA Saib… - Metabolites, 2023 - mdpi.com
… Pan CDK inhibitors remain the chief therapeutic option for the treatment of CDK5-related
illnesses [22]. First-generation pan CDK inhibitors, Roscovitine and flavopiridol, have entered …

[HTML][HTML] Biological evaluation of arylsemicarbazone derivatives as potential anticancer agents

AC Nascimento da Cruz, DJ Brondani… - Pharmaceuticals, 2019 - mdpi.com
… kinase inhibition test, it was found that 3c inhibited the CDK5/… is probably related to strong
inhibition of protein kinases, which … MZH and MMR performed the molecular modeling study; …

[HTML][HTML] Inhibitors of cyclin-dependent kinases: types and their mechanism of action

P Łukasik, I Baranowska-Bosiacka… - … Journal of Molecular …, 2021 - mdpi.com
… , Flavopiridol (Alvocidib) 4 (Figure 3), a flavonoid derived from … a very effective small molecule
inhibitor against CDK5 (IC 50 = … that highly selective and potent inhibitors of human cyclin-…

Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors

AM El Kerdawy, AA Osman, MA Zaater - Journal of Molecular Modeling, 2019 - Springer
… After removing duplicate hits from the hit list obtained from ZINCPharmer, three filters
were … Compound 6 is a very potent inhibitor of GSK-3β with IC 50 of 3.4 nM. Its 2-aminopyridyl …

Identification and comparison of plant-derived scaffolds as selective CDK5 inhibitors against standard molecules: Insights from umbrella sampling simulations

V kumar Bhardwaj, P Das, R Purohit - Journal of Molecular Liquids, 2022 - Elsevier
… selective CDK5 inhibitors molecules by utilizing molecular docking, conventional, steered,
and biased MD simulations. We explored the potential of in-house developed, plant-derived (…

Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update

T Wu, Z Qin, Y Tian, J Wang, C Xu, Z Li… - Journal of medicinal …, 2020 - ACS Publications
… I study of compound 13, a potent inhibitor targeting CDK 2, 7, … for CDK9 over other CDKs
(except CDK5, 43-fold). Importantly, … design, synthesis, and biological evaluation of potent and …